Email Us Here

Clinician Anita Davidson and Biochemist Dr. Don Davidson Advance CBT300, an Investigational Biologic Candidate for Cancer Recurrence and Drug Resistance

Creative Biotherapeutics, LLC, led by Anita Davidson, DPT, and Dr. Don Davidson, is advancing CBT300, an investigational biologic therapeutic candidate targeting drug resistance, immune evasion, recurrence, and metastasis in cancer treatment failure.